Catalyst Pharmaceuticals
In Terry Smith's portfolio · Fundsmith
Ticker CPRX
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Fundsmith 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Sell | 0 | |
| Q1 2026 | Reduce 75% | 844,887 | 0.1% |
| Q4 2025 | No change | 3,363,807 | 0.3% |
| Q3 2025 | Add 24% | 3,363,807 | 0.3% |
| Q2 2025 | Add 26% | 2,709,086 | 0.2% |
| Q1 2025 | Buy | 2,151,274 | 0.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.